146 related articles for article (PubMed ID: 31924153)
1. A Single Medical Marker for Diagnosis of Methamphetamine Addiction - DNA Methylation of SHATI/NAT8L Promoter Sites from Patient Blood.
Yuka K; Nishizawa D; Hasegawa J; Uno K; Miyanishi H; Ujike H; Ozaki N; Inada T; Iwata N; Sora I; Iyo M; Yamada M; Kondo N; Won MJ; Naruse N; Uehara-Aoyama K; Ikeda K; Nitta A
Curr Pharm Des; 2020; 26(2):260-264. PubMed ID: 31924153
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
3. Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.
Uno K; Kikuchi Y; Iwata M; Uehara T; Matsuoka T; Sumiyoshi T; Okamoto Y; Jinno H; Takada T; Furukawa-Hibi Y; Nabeshima T; Miyamoto Y; Nitta A
PLoS One; 2016; 11(6):e0157959. PubMed ID: 27348532
[TBL] [Abstract][Full Text] [Related]
4. Investigating DNA Methylation of SHATI/NAT8L Promoter Sites in Blood of Unmedicated Patients with Major Depressive Disorder.
Miyanishi H; Uno K; Iwata M; Kikuchi Y; Yamamori H; Yasuda Y; Ohi K; Hashimoto R; Hattori K; Yoshida S; Goto YI; Sumiyoshi T; Nitta A
Biol Pharm Bull; 2020; 43(7):1067-1072. PubMed ID: 32612069
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A
Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655
[TBL] [Abstract][Full Text] [Related]
7. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers.
Izuo N; Miyanishi H; Nishizawa D; Fujii T; Hasegawa J; Sato N; Tanioka F; Sugimura H; Ikeda K; Nitta A
Neuropsychopharmacol Rep; 2023 Dec; 43(4):570-575. PubMed ID: 37668111
[TBL] [Abstract][Full Text] [Related]
9. Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate.
Toriumi K; Tanaka J; Mamiya T; Alkam T; Kim HC; Nitta A; Nabeshima T
Behav Brain Res; 2018 Feb; 339():207-214. PubMed ID: 29203337
[TBL] [Abstract][Full Text] [Related]
10. Induction of neuronal axon outgrowth by Shati/Nat8l by energy metabolism in mice cultured neurons.
Sumi K; Uno K; Matsumura S; Miyamoto Y; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Nitta A
Neuroreport; 2015 Sep; 26(13):740-6. PubMed ID: 26164607
[TBL] [Abstract][Full Text] [Related]
11. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
Niwa M; Nitta A; Mizoguchi H; Ito Y; Noda Y; Nagai T; Nabeshima T
J Neurosci; 2007 Jul; 27(28):7604-15. PubMed ID: 17626222
[TBL] [Abstract][Full Text] [Related]
12. Deletion of SHATI/NAT8L decreases the N-acetylaspartate content in the brain and induces behavioral deficits, which can be ameliorated by administering N-acetylaspartate.
Toriumi K; Mamiya T; Song Z; Honjo T; Watanabe H; Tanaka J; Kondo M; Mouri A; Kim HC; Nitta A; Fukushima T; Nabeshima T
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2108-17. PubMed ID: 26361739
[TBL] [Abstract][Full Text] [Related]
13. Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence.
Veerasakul S; Watiktinkorn P; Thanoi S; Dalton CF; Fachim HA; Nudmamud-Thanoi S; Reynolds GP
Pharmacogenomics; 2017 Sep; 18(14):1317-1322. PubMed ID: 28835159
[TBL] [Abstract][Full Text] [Related]
14. Behavioral impairment in SHATI/NAT8L knockout mice via dysfunction of myelination development.
Sumi K; Uno K; Noike H; Tomohiro T; Hatanaka Y; Furukawa-Hibi Y; Nabeshima T; Miyamoto Y; Nitta A
Sci Rep; 2017 Dec; 7(1):16872. PubMed ID: 29203794
[TBL] [Abstract][Full Text] [Related]
15. Impairment of cognitive function induced by Shati/Nat8l overexpression in the prefrontal cortex of mice.
Haddar M; Azuma K; Izuo N; Kyosuke U; Asano T; Muramatsu SI; Nitta A
Behav Brain Res; 2021 Jan; 397():112938. PubMed ID: 32998043
[TBL] [Abstract][Full Text] [Related]
16. [The role of a molecule associated with drug dependence, shati/nat8l].
Miyamoto Y; Saika E; Hori E; Iegaki N; Sumi K; Nabeshima T; Muramatsu S; Nishijo H; Uno K; Nitta A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):167-73. PubMed ID: 25069253
[TBL] [Abstract][Full Text] [Related]
17. Shati/Nat8l Overexpression Improves Cognitive Decline by Upregulating Neuronal Trophic Factor in Alzheimer's Disease Model Mice.
Chino K; Izuo N; Noike H; Uno K; Kuboyama T; Tohda C; Muramatsu SI; Nitta A
Neurochem Res; 2022 Sep; 47(9):2805-2814. PubMed ID: 35759136
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin inhibits methamphetamine-associated learning and memory alterations by regulating DNA methylation at the Synaptophysin promoter.
Fan XY; Yang JY; Dong YX; Hou Y; Liu S; Wu CF
Addict Biol; 2020 Jan; 25(1):e12697. PubMed ID: 30585381
[TBL] [Abstract][Full Text] [Related]
19. Shati/Nat8l deficiency disrupts adult neurogenesis and causes attentional impairment through dopaminergic neuronal dysfunction in the dentate gyrus.
Wulaer B; Kunisawa K; Hada K; Jaya Suento W; Kubota H; Iida T; Kosuge A; Nagai T; Yamada K; Nitta A; Yamamoto Y; Saito K; Mouri A; Nabeshima T
J Neurochem; 2021 May; 157(3):642-655. PubMed ID: 32275776
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
